Utility of EORTC and CUETO Scoring Models in the Estimation of Recurrence and Progression of Non-Muscle-Invasive Bladder Cancer

被引:0
作者
Alaoui, Chaimae Hafidi [1 ,2 ]
Tetou, Mohammed [3 ,5 ]
Hassan, Ilias [3 ,5 ]
El Azzouzi, Meryem [1 ,5 ]
El Ahanidi, Hajar [1 ,5 ]
Filali-Maltouf, Abdelkarim [2 ]
Chaoui, Imane [1 ]
Bensaid, Mounia [4 ]
Benbacer, Laila [1 ]
Oukabli, Mohamed [4 ,5 ]
Al Bouzidi, Abderrahmane [5 ]
Attaleb, Mohammed [1 ]
El Mzibri, Mohammed [1 ]
Ameur, Ahmed [3 ,5 ]
机构
[1] CNESTEN, Biol & Med Res Unit, Rabat, Morocco
[2] Mohammed V Univ Rabat, Fac Sci, Microbiol & Mol Biol Lab, Rabat, Morocco
[3] Mohammed V Mil Teaching Hosp Rabat, Dept Urol, Rabat, Morocco
[4] Mohammed V Mil Teaching Hosp Rabat, Dept Pathol, Rabat, Morocco
[5] Mohammed V Univ Rabat, Fac Med & Pharm Rabat, Rabat, Morocco
来源
EURASIAN JOURNAL OF MEDICINE AND ONCOLOGY | 2022年 / 6卷 / 02期
关键词
EORTC; CUETO; recurrence; progression; NMIBC; Morocco; PREDICTING RECURRENCE; RISK TABLES; SCORES; TA;
D O I
10.14744/ejmo.2022.99203
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objectives: Worldwide, Non-Muscle-Invasive Bladder Cancer (NMIBC) patients are characterized by a high rate of recurrence and progression highlighting the need for a valuable prognostic estimation for better management of this disease. Thus, the present preliminary study was planned to evaluate the validation of the European Organization for Research and Treatment of Cancer (EORTC) and the Spanish Urological Club for Oncological Treatment (CUETO) risk tables to predict recurrence and progression in Moroccan patients with NMIBC. Methods: A total of 56 NMIBC patients that have undergone transurethral resection of bladder tumor (TURBT), between January 2017 and May 2021, were recruited. The recurrence and progression rates at 1 and 5 years were calculated for each patient using EORTC and CUETO scoring models and compared to EORTC and CUETO risk tables. KaplanMeier was performed to validate stratification and difference between the four groups obtained. A univariate analysis using the Cox regression test was realized to evaluate the association between prognostic factors with recurrence and progression of the disease. Results: For the 56 NMIBC patients, the median follow-up duration was 49.68 months. In this cohort, 43 patients had recurrent tumors, and 27 showed progression to an advanced stage and/or grade. At 1-year progression and recurrence rates were higher than the values predicted by the EORTC and CUETO risk tables, while both tables overestimate the long-term risk probabilities of recurrence and progression. Only the CUETO model successfully stratified our patients with statistically significant differences between the four groups of recurrence (p=0.005). Of particular interest, univariate Cox analysis indicated that only prior recurrence rate had a significant effect on both recurrence-free survival (p=0.04) and progression-free survival (p=0.037). Conclusion: CUETO scoring model is better than EORTC for recurrence stratification in Moroccan patients with NMIBC. Both models overestimate risk in 1-year and underestimate risk in 5-years. A prospective study should be realized in large cohorts to establish an ideal prognosis model for Moroccan NMIBC patients.
引用
收藏
页码:121 / 129
页数:9
相关论文
共 21 条
[1]   External validation of EORTC risk scores to predict recurrence after transurethral resection of brazilian patients with non-muscle invasive bladder cancer stages Ta and T1 [J].
Almeida, Gilberto L. ;
Busato, Wilson F. S., Jr. ;
Ribas, Carmen Marcondes ;
Ribas-Filho, Jurandir Marcondes ;
De Cobelli, Ottavio .
INTERNATIONAL BRAZ J UROL, 2016, 42 (05) :932-941
[2]   Recurrence and Progression in Non-Muscle-Invasive Bladder Cancer Using EORTC Risk Tables [J].
Altieri, Vincenzo Maria ;
Castellucci, Roberto ;
Palumbo, Pietro ;
Verratti, Vittore ;
Sut, Michal ;
Olivieri, Raffaella ;
Manco, Rossella ;
Ricciardulli, Stefano ;
Nicolai, Michele ;
Criniti, Pasquale ;
Tenaglia, Raffaele Lanfranco .
UROLOGIA INTERNATIONALIS, 2012, 89 (01) :61-66
[3]   Best practice in the treatment of nonmuscle invasive bladder cancer [J].
Anastasiadis, Anastasios ;
de Reijke, Theo M. .
THERAPEUTIC ADVANCES IN UROLOGY, 2012, 4 (01) :13-32
[4]   EORTC Risk Model to Predict Progression in Patients With NoneMuscle-Invasive Bladder Cancer: Is It Safe to Use in Clinical Practice? [J].
Busato Junior, Wilson F. S. ;
Almeida, Gilberto Laurino ;
Ribas, Carmen A. P. M. ;
Ribas Filho, Jurandir M. ;
De Cobelli, Ottavio .
CLINICAL GENITOURINARY CANCER, 2016, 14 (02) :176-182
[5]   Prognostic Significance of the Neutrophil-to-Lymphocyte Ratio in Patients with Non-Muscle Invasive Bladder Cancer treated with Intravesical Bacillus Calmette-Guerin and the Relationship with the CUETO Scoring Model [J].
Chung, Jae-Wook ;
Kim, Jin Woo ;
Lee, Eun Hye ;
Chun, So Young ;
Park, Dong Jin ;
Byeon, Kyeong Hyeon ;
Choi, Seock Hwan ;
Lee, Jun Nyung ;
Kim, Bum Soo ;
Kim, Hyun Tae ;
Yoo, Eun Sang ;
Kwon, Tae Gyun ;
Ha, Yun-Sok ;
Kim, Tae-Hwan .
UROLOGY JOURNAL, 2022, 19 (04) :281-288
[6]   Epidemiology of Bladder Cancer: A Systematic Review and Contemporary Update of Risk Factors in 2018 [J].
Cumberbatch, Marcus George Kwesi ;
Jubber, Ibrahim ;
Black, Peter C. ;
Esperto, Francesco ;
Figueroa, Jonine D. ;
Kamat, Ashish M. ;
Kiemeney, Lambertus ;
Lotan, Yair ;
Pang, Karl ;
Silverman, Debra T. ;
Znaor, Ariana ;
Catto, James W. F. .
EUROPEAN UROLOGY, 2018, 74 (06) :784-795
[7]  
Dalkilic A, 2019, UROL J, V16, P37, DOI 10.22037/uj.v0i0.4091
[8]  
Dovey Z, UROL ONCOL 2022, V40
[9]   Effect of anticoagulants and antiplatelet agents on the efficacy of intravesical BCG treatment of bladder cancer: A systematic review [J].
Fahmy, Nader ;
Lazo-Langner, Alejandro ;
Iansavichene, Alla E. ;
Pautler, Stephen E. .
CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2013, 7 (11-12) :E740-E749
[10]   Predicting Nonmuscle Invasive Bladder Cancer Recurrence and Progression in Patients Treated With Bacillus Calmette-Guerin: The CUETO Scoring Model [J].
Fernandez-Gomez, Jesus ;
Madero, Rosario ;
Solsona, Eduardo ;
Unda, Miguel ;
Martinez-Pineiro, Luis ;
Gonzalez, Marcelino ;
Portillo, Jose ;
Ojea, Antonio ;
Pertusa, Carlos ;
Rodriguez-Molina, Jesus ;
Emilio Camacho, Jose ;
Rabadan, Mariano ;
Astobieta, Ander ;
Montesinos, Manuel ;
Isorna, Santiago ;
Muntanola, Pedro ;
Gimeno, Anabel ;
Blas, Miguel ;
Antonio Martinez-Pineiro, Jose .
JOURNAL OF UROLOGY, 2009, 182 (05) :2195-2203